Report cover image

Global Lipid Contract Manufacturing Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 197 Pages
SKU # APRC20361073

Description

Summary

According to APO Research, The global Lipid Contract Manufacturing market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Lipid Contract Manufacturing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lipid Contract Manufacturing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Lipid Contract Manufacturing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Lipid Contract Manufacturing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Lipid Contract Manufacturing include Acuitas Therapeutics, Avanti Polar Lipids, Corden Pharma, Evonik, Exelead, Genevant Sciences, Lipoid, Nippon Fine Chemical and Polymun Scientific, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Lipid Contract Manufacturing, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Lipid Contract Manufacturing, also provides the revenue of main regions and countries. Of the upcoming market potential for Lipid Contract Manufacturing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lipid Contract Manufacturing revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Lipid Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Lipid Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Lipid Contract Manufacturing Segment by Company

Acuitas Therapeutics
Avanti Polar Lipids
Corden Pharma
Evonik
Exelead
Genevant Sciences
Lipoid
Nippon Fine Chemical
Polymun Scientific
Precision NanoSystems
Merck KGaA
Lipid Contract Manufacturing Segment by Type

Liposomes
Lipid Nanoparticles
Lipid Contract Manufacturing Segment by Application

Clinical
Preclinical
Commercial
Lipid Contract Manufacturing Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lipid Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Contract Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Lipid Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Lipid Contract Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lipid Contract Manufacturing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Lipid Contract Manufacturing Market by Type
1.2.1 Global Lipid Contract Manufacturing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Liposomes
1.2.3 Lipid Nanoparticles
1.3 Lipid Contract Manufacturing Market by Application
1.3.1 Global Lipid Contract Manufacturing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Preclinical
1.3.4 Commercial
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Lipid Contract Manufacturing Market Dynamics
2.1 Lipid Contract Manufacturing Industry Trends
2.2 Lipid Contract Manufacturing Industry Drivers
2.3 Lipid Contract Manufacturing Industry Opportunities and Challenges
2.4 Lipid Contract Manufacturing Industry Restraints
3 Global Growth Perspective
3.1 Global Lipid Contract Manufacturing Market Perspective (2020-2031)
3.2 Global Lipid Contract Manufacturing Growth Trends by Region
3.2.1 Global Lipid Contract Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Lipid Contract Manufacturing Market Size by Region (2020-2025)
3.2.3 Global Lipid Contract Manufacturing Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Lipid Contract Manufacturing Revenue by Players
4.1.1 Global Lipid Contract Manufacturing Revenue by Players (2020-2025)
4.1.2 Global Lipid Contract Manufacturing Revenue Market Share by Players (2020-2025)
4.1.3 Global Lipid Contract Manufacturing Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Lipid Contract Manufacturing Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Lipid Contract Manufacturing Key Players Headquarters & Area Served
4.4 Global Lipid Contract Manufacturing Players, Product Type & Application
4.5 Global Lipid Contract Manufacturing Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Lipid Contract Manufacturing Market CR5 and HHI
4.6.3 2024 Lipid Contract Manufacturing Tier 1, Tier 2, and Tier 3
5 Lipid Contract Manufacturing Market Size by Type
5.1 Global Lipid Contract Manufacturing Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Lipid Contract Manufacturing Revenue by Type (2020-2031)
5.3 Global Lipid Contract Manufacturing Revenue Market Share by Type (2020-2031)
6 Lipid Contract Manufacturing Market Size by Application
6.1 Global Lipid Contract Manufacturing Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Lipid Contract Manufacturing Revenue by Application (2020-2031)
6.3 Global Lipid Contract Manufacturing Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Acuitas Therapeutics
7.1.1 Acuitas Therapeutics Comapny Information
7.1.2 Acuitas Therapeutics Business Overview
7.1.3 Acuitas Therapeutics Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.1.4 Acuitas Therapeutics Lipid Contract Manufacturing Product Portfolio
7.1.5 Acuitas Therapeutics Recent Developments
7.2 Avanti Polar Lipids
7.2.1 Avanti Polar Lipids Comapny Information
7.2.2 Avanti Polar Lipids Business Overview
7.2.3 Avanti Polar Lipids Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.2.4 Avanti Polar Lipids Lipid Contract Manufacturing Product Portfolio
7.2.5 Avanti Polar Lipids Recent Developments
7.3 Corden Pharma
7.3.1 Corden Pharma Comapny Information
7.3.2 Corden Pharma Business Overview
7.3.3 Corden Pharma Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.3.4 Corden Pharma Lipid Contract Manufacturing Product Portfolio
7.3.5 Corden Pharma Recent Developments
7.4 Evonik
7.4.1 Evonik Comapny Information
7.4.2 Evonik Business Overview
7.4.3 Evonik Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.4.4 Evonik Lipid Contract Manufacturing Product Portfolio
7.4.5 Evonik Recent Developments
7.5 Exelead
7.5.1 Exelead Comapny Information
7.5.2 Exelead Business Overview
7.5.3 Exelead Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.5.4 Exelead Lipid Contract Manufacturing Product Portfolio
7.5.5 Exelead Recent Developments
7.6 Genevant Sciences
7.6.1 Genevant Sciences Comapny Information
7.6.2 Genevant Sciences Business Overview
7.6.3 Genevant Sciences Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.6.4 Genevant Sciences Lipid Contract Manufacturing Product Portfolio
7.6.5 Genevant Sciences Recent Developments
7.7 Lipoid
7.7.1 Lipoid Comapny Information
7.7.2 Lipoid Business Overview
7.7.3 Lipoid Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.7.4 Lipoid Lipid Contract Manufacturing Product Portfolio
7.7.5 Lipoid Recent Developments
7.8 Nippon Fine Chemical
7.8.1 Nippon Fine Chemical Comapny Information
7.8.2 Nippon Fine Chemical Business Overview
7.8.3 Nippon Fine Chemical Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.8.4 Nippon Fine Chemical Lipid Contract Manufacturing Product Portfolio
7.8.5 Nippon Fine Chemical Recent Developments
7.9 Polymun Scientific
7.9.1 Polymun Scientific Comapny Information
7.9.2 Polymun Scientific Business Overview
7.9.3 Polymun Scientific Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.9.4 Polymun Scientific Lipid Contract Manufacturing Product Portfolio
7.9.5 Polymun Scientific Recent Developments
7.10 Precision NanoSystems
7.10.1 Precision NanoSystems Comapny Information
7.10.2 Precision NanoSystems Business Overview
7.10.3 Precision NanoSystems Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.10.4 Precision NanoSystems Lipid Contract Manufacturing Product Portfolio
7.10.5 Precision NanoSystems Recent Developments
7.11 Merck KGaA
7.11.1 Merck KGaA Comapny Information
7.11.2 Merck KGaA Business Overview
7.11.3 Merck KGaA Lipid Contract Manufacturing Revenue and Gross Margin (2020-2025)
7.11.4 Merck KGaA Lipid Contract Manufacturing Product Portfolio
7.11.5 Merck KGaA Recent Developments
8 North America
8.1 North America Lipid Contract Manufacturing Revenue (2020-2031)
8.2 North America Lipid Contract Manufacturing Revenue by Type (2020-2031)
8.2.1 North America Lipid Contract Manufacturing Revenue by Type (2020-2025)
8.2.2 North America Lipid Contract Manufacturing Revenue by Type (2026-2031)
8.3 North America Lipid Contract Manufacturing Revenue Share by Type (2020-2031)
8.4 North America Lipid Contract Manufacturing Revenue by Application (2020-2031)
8.4.1 North America Lipid Contract Manufacturing Revenue by Application (2020-2025)
8.4.2 North America Lipid Contract Manufacturing Revenue by Application (2026-2031)
8.5 North America Lipid Contract Manufacturing Revenue Share by Application (2020-2031)
8.6 North America Lipid Contract Manufacturing Revenue by Country
8.6.1 North America Lipid Contract Manufacturing Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Lipid Contract Manufacturing Revenue by Country (2020-2025)
8.6.3 North America Lipid Contract Manufacturing Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Lipid Contract Manufacturing Revenue (2020-2031)
9.2 Europe Lipid Contract Manufacturing Revenue by Type (2020-2031)
9.2.1 Europe Lipid Contract Manufacturing Revenue by Type (2020-2025)
9.2.2 Europe Lipid Contract Manufacturing Revenue by Type (2026-2031)
9.3 Europe Lipid Contract Manufacturing Revenue Share by Type (2020-2031)
9.4 Europe Lipid Contract Manufacturing Revenue by Application (2020-2031)
9.4.1 Europe Lipid Contract Manufacturing Revenue by Application (2020-2025)
9.4.2 Europe Lipid Contract Manufacturing Revenue by Application (2026-2031)
9.5 Europe Lipid Contract Manufacturing Revenue Share by Application (2020-2031)
9.6 Europe Lipid Contract Manufacturing Revenue by Country
9.6.1 Europe Lipid Contract Manufacturing Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Lipid Contract Manufacturing Revenue by Country (2020-2025)
9.6.3 Europe Lipid Contract Manufacturing Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Lipid Contract Manufacturing Revenue (2020-2031)
10.2 China Lipid Contract Manufacturing Revenue by Type (2020-2031)
10.2.1 China Lipid Contract Manufacturing Revenue by Type (2020-2025)
10.2.2 China Lipid Contract Manufacturing Revenue by Type (2026-2031)
10.3 China Lipid Contract Manufacturing Revenue Share by Type (2020-2031)
10.4 China Lipid Contract Manufacturing Revenue by Application (2020-2031)
10.4.1 China Lipid Contract Manufacturing Revenue by Application (2020-2025)
10.4.2 China Lipid Contract Manufacturing Revenue by Application (2026-2031)
10.5 China Lipid Contract Manufacturing Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Lipid Contract Manufacturing Revenue (2020-2031)
11.2 Asia Lipid Contract Manufacturing Revenue by Type (2020-2031)
11.2.1 Asia Lipid Contract Manufacturing Revenue by Type (2020-2025)
11.2.2 Asia Lipid Contract Manufacturing Revenue by Type (2026-2031)
11.3 Asia Lipid Contract Manufacturing Revenue Share by Type (2020-2031)
11.4 Asia Lipid Contract Manufacturing Revenue by Application (2020-2031)
11.4.1 Asia Lipid Contract Manufacturing Revenue by Application (2020-2025)
11.4.2 Asia Lipid Contract Manufacturing Revenue by Application (2026-2031)
11.5 Asia Lipid Contract Manufacturing Revenue Share by Application (2020-2031)
11.6 Asia Lipid Contract Manufacturing Revenue by Country
11.6.1 Asia Lipid Contract Manufacturing Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Lipid Contract Manufacturing Revenue by Country (2020-2025)
11.6.3 Asia Lipid Contract Manufacturing Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Lipid Contract Manufacturing Revenue (2020-2031)
12.2 SAMEA Lipid Contract Manufacturing Revenue by Type (2020-2031)
12.2.1 SAMEA Lipid Contract Manufacturing Revenue by Type (2020-2025)
12.2.2 SAMEA Lipid Contract Manufacturing Revenue by Type (2026-2031)
12.3 SAMEA Lipid Contract Manufacturing Revenue Share by Type (2020-2031)
12.4 SAMEA Lipid Contract Manufacturing Revenue by Application (2020-2031)
12.4.1 SAMEA Lipid Contract Manufacturing Revenue by Application (2020-2025)
12.4.2 SAMEA Lipid Contract Manufacturing Revenue by Application (2026-2031)
12.5 SAMEA Lipid Contract Manufacturing Revenue Share by Application (2020-2031)
12.6 SAMEA Lipid Contract Manufacturing Revenue by Country
12.6.1 SAMEA Lipid Contract Manufacturing Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Lipid Contract Manufacturing Revenue by Country (2020-2025)
12.6.3 SAMEA Lipid Contract Manufacturing Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.